glp-1 for kidney disease agonists in the treatment of chronic in type 2 diabetes and obesity GLP-1 in kidney disease? #obesitydoctor

Therefore, additional clinical trials must be carried out to increase the effectiveness and lower the negative effects of FMT treatment in MASLD/MASH

Talk to HR If you have insurance through your employer, your HR/Benefits department may be able to help: Self-funded employers (typically larger companies) can modify coveragethey're not bound by standard Cigna rules Ask HR to advocate for adding GLP-1 coverage at the next plan renewal Request the $200/month Evernorth cap be added if your plan doesn't have it CIGNA WEGOVY COVERAGE Frequently Asked Questions It depends on your Cigna plan

It is advisable to consult a doctor for specific treatment options

Conflict of Interest:Hyun-Jin Kim has been the editor of the CardioMetabolic Syndrome Journal since 2021 and was not involved in the review process of this article

This step-by-step approach helps reduce side effects and allows the body to adjust